Jonathan Mow is listed as an executive officer and director on 4 SEC Form D filings by 1 issuer between Mar 2015 and Sep 2018: PhaseBio Pharmaceuticals Inc (Malvern, PA — pharmaceuticals — 2015–2018; $48.5M reported sold to 20 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Clay Thorp (4 shared filings), Justin Klein (4 shared filings), Ashutosh Chilkoti (3 shared filings), Asish Xavier (3 shared filings), Guy Fish (3 shared filings) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jonathan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Jonathan Mow and found 7 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.